Lake Street Maintains Buy on TELA Bio, Lowers Price Target to $3

Benzinga · 12/01/2025 17:03
Lake Street analyst Frank Takkinen maintains TELA Bio (NASDAQ:TELA) with a Buy and lowers the price target from $6 to $3.